Cargando…

A member of the Ras oncogene family, RAP1A, mediates antileishmanial activity of monastrol

OBJECTIVES: To investigate the mode of action of monastrol in intracellular Leishmania. METHODS: Microarray experiments were conducted on an Affymetrix GeneChip(®) Human Genome U133 Plus 2.0 Array, to determine the genes that encode proteins related to pathological alterations of cell signalling pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Jaspreet, Dutta, Sujoy, Chang, Kwang-Poo, Singh, Neeloo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625431/ https://www.ncbi.nlm.nih.gov/pubmed/23292345 http://dx.doi.org/10.1093/jac/dks507

Ejemplares similares

Monastrol derivatives: in silico and in vitro cytotoxicity assessments
por: Bidram, Zahra, et al.
Publicado: (2020)

Small-molecule and mutational analysis of allosteric Eg5 inhibition by monastrol
por: Maliga, Zoltan, et al.
Publicado: (2006)

Bioinformatic Analysis of Leishmania donovani Long-Chain Fatty Acid-CoA Ligase as a Novel Drug Target
por: Kaur, Jaspreet, et al.
Publicado: (2011)

Oncogenic RAS promotes MYC protein stability by upregulating the expression of the inhibitor of apoptosis protein family member Survivin
por: Chang, Wen-Hsuan, et al.
Publicado: (2022)

286 Association Analysis of Member RAS Oncogene Family Gene Polymorphisms with Aspirin Intolerance in Asthmatic Patients
por: Kim, Myung ok, et al.
Publicado: (2012)

Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5
por: Kapoor, Tarun M., et al.
Publicado: (2000)

Structural basis of inactivation of Ras and Rap1 small GTPases by Ras/Rap1-specific endopeptidase from the sepsis-causing pathogen Vibrio vulnificus
por: Jang, Song Yee, et al.
Publicado: (2018)

Sos-mediated cross activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
por: Jeng, Hao-Hsuan, et al.
Publicado: (2012)

Evolutionary comparison of prenylation pathway in kinetoplastid Leishmania and its sister Leptomonas
por: Chauhan, Indira Singh, et al.
Publicado: (2015)

Mitotic Slippage and Expression of Survivin Are Linked to Differential Sensitivity of Human Cancer Cell-Lines to the Kinesin-5 Inhibitor Monastrol
por: Asraf, Hila, et al.
Publicado: (2015)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Harvey-ras oncogene restriction fragment alleles in familial melanoma kindreds.
por: Sutherland, C., et al.
Publicado: (1986)

Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation
por: Lock, Rebecca, et al.
Publicado: (2011)

Developments in Diagnosis and Antileishmanial Drugs
por: Bhargava, Prachi, et al.
Publicado: (2012)

Zeolite catalyzed solvent-free one-pot synthesis of dihydropyrimidin-2(1H)-ones – A practical synthesis of monastrol
por: Kulkarni, Mukund G, et al.
Publicado: (2009)

Akt-mediated Ephexin1–Ras interaction promotes oncogenic Ras signaling and colorectal and lung cancer cell proliferation
por: Kim, Jeeho, et al.
Publicado: (2021)

The small GTPases Ras and Rap1 bind to and control TORC2 activity
por: Khanna, Ankita, et al.
Publicado: (2016)

Strategies to Overcome Antileishmanial Drugs Unresponsiveness
por: Sundar, Shyam, et al.
Publicado: (2014)

Molecular Analysis of Oncogenes, ras Family Genes (N‐ras, K‐ras, H‐ras), myc Family Genes (c‐myc, N‐myc) and mdm2 in Natural Killer Cell Neoplasms
por: Sugimoto, Kei‐ji, et al.
Publicado: (2002)

Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum.
por: Spandidos, D. A., et al.
Publicado: (1984)

The Ras-association domain family (RASSF) members and their role in human tumourigenesis
por: van der Weyden, Louise, et al.
Publicado: (2007)

Promoter Methylation Status of Ras-Association Domain Family Members in Pheochromocytoma
por: Richter, Antje M., et al.
Publicado: (2015)

Synthesis and molecular modeling of six novel monastrol analogues: evaluation of cytotoxicity and kinesin inhibitory activity against HeLa cell line
por: Abnous, Khalil, et al.
Publicado: (2013)

Ras Oncogene-Mediated Progressive Silencing of Extracellular Superoxide Dismutase in Tumorigenesis
por: Cammarota, Francesca, et al.
Publicado: (2015)

Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity
por: Henkels, Karen M., et al.
Publicado: (2021)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

IL1RAP potentiates multiple oncogenic signaling pathways in AML
por: Mitchell, Kelly, et al.
Publicado: (2018)

Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
por: Augsten, Martin, et al.
Publicado: (2014)

Structure, signaling and the drug discovery of the Ras oncogene protein
por: Han, Chang Woo, et al.
Publicado: (2017)

SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras
por: Lilja, Johanna, et al.
Publicado: (2017)

Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer
por: Cui, Guoliang, et al.
Publicado: (2021)

An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1
por: Singh, Neeloo, et al.
Publicado: (2009)

Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase
por: Srivastava, Jitendra Kumar, et al.
Publicado: (2017)

RASOnD - A comprehensive resource and search tool for RAS superfamily oncogenes from various species
por: Kulsum, Umay, et al.
Publicado: (2011)

Activation of RAS family members confers resistance to ROS1 targeting drugs
por: Cargnelutti, Marilisa, et al.
Publicado: (2014)

The role of RAS oncogenes in controlling epithelial mechanics
por: Nyga, Agata, et al.
Publicado: (2023)

Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB)
por: Firdessa, Rebuma, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_br2hd7dp639qui6v7obj4sa3h1